{"title":"Testes urinários Drugdiag® Cassette","description":"\u003csection class=\"ama-collection-description\"\u003e\n \u003ch2\u003eTestes urinários Drugdiag® cassete para rastreio de drogas\u003c\/h2\u003e\n\n \u003cp\u003e\n Os \u003cstrong\u003etestes urinários Drugdiag® cassete\u003c\/strong\u003e oferecidos pela \u003cstrong\u003eAMA Prévention\u003c\/strong\u003e\n permitem realizar um \u003cstrong\u003erastreio urinário de drogas\u003c\/strong\u003e simples, rápido e legível.\n Este formato é adequado às necessidades de \u003cstrong\u003eempresas\u003c\/strong\u003e, \u003cstrong\u003eprofissionais de saúde\u003c\/strong\u003e,\n \u003cstrong\u003eestruturas de prevenção\u003c\/strong\u003e, \u003cstrong\u003ecoletividades\u003c\/strong\u003e e \u003cstrong\u003eparticulares\u003c\/strong\u003e\n que procuram uma solução fiável para detetar diferentes famílias de substâncias psicoativas.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Conforme o modelo, os testes urinários Drugdiag® cassete podem permitir a deteção de\n \u003cstrong\u003eTHC\u003c\/strong\u003e, \u003cstrong\u003ecocaína\u003c\/strong\u003e, \u003cstrong\u003eopiáceos\u003c\/strong\u003e,\n \u003cstrong\u003eanfetaminas\u003c\/strong\u003e, \u003cstrong\u003emetanfetaminas\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e,\n \u003cstrong\u003ebenzodiazepinas\u003c\/strong\u003e, \u003cstrong\u003emetadona\u003c\/strong\u003e, \u003cstrong\u003ebuprenorfina\u003c\/strong\u003e,\n \u003cstrong\u003ebarbitúricos\u003c\/strong\u003e ou ainda \u003cstrong\u003eantidepressivos tricíclicos\u003c\/strong\u003e,\n conforme a referência escolhida.\n \u003c\/p\u003e\n\n \u003ch3\u003eDrugdiag® cassete: um formato preciso, legível e prático\u003c\/h3\u003e\n\n \u003cp\u003e\n O \u003cstrong\u003eteste urinário Drugdiag® cassete\u003c\/strong\u003e utiliza-se após recolha de uma amostra de urina.\n Basta depositar algumas gotas nos poços do teste com a pipeta fornecida.\n As tiras reativas mostram depois um resultado visual em poucos minutos, com uma leitura clara\n diretamente no dispositivo.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Este formato cassete é particularmente apreciado pela sua \u003cstrong\u003esimplicidade de utilização\u003c\/strong\u003e,\n \u003cstrong\u003ecusto controlado\u003c\/strong\u003e e capacidade para rastrear várias substâncias conforme o modelo.\n Algumas referências permitem um rastreio multi-drogas até \u003cstrong\u003e11 substâncias simultaneamente\u003c\/strong\u003e,\n tornando-se uma solução adequada para campanhas de prevenção, necessidades profissionais e controlos pontuais.\n \u003c\/p\u003e\n\n \u003ch3\u003eUma gama desenvolvida por um fabricante francês especializado\u003c\/h3\u003e\n\n \u003cp\u003e\n Os testes urinários Drugdiag® são desenvolvidos pela \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, fabricante francês especializado\n em testes de diagnóstico rápido. A AMA Prévention seleciona estes dispositivos pela sua legibilidade,\n facilidade de implementação e adaptação aos usos profissionais e particulares.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Conforme as referências, alguns testes podem beneficiar de características ou menções específicas,\n nomeadamente a \u003cstrong\u003emarca CE\u003c\/strong\u003e, uma fabricação controlada segundo padrões de qualidade aplicáveis,\n o \u003cstrong\u003erótulo Alsace Cœur\u003c\/strong\u003e ou a menção \u003cstrong\u003eUtilizado pelas Forças Armadas Francesas\u003c\/strong\u003e\n quando aplicável ao produto selecionado.\n \u003c\/p\u003e\n\n \u003ch3\u003eTestes urinários para empresas, saúde, prevenção e uso privado\u003c\/h3\u003e\n\n \u003cp\u003e\n Os \u003cstrong\u003etestes urinários de rastreio\u003c\/strong\u003e são usados em muitos contextos:\n prevenção em empresas, autoavaliação, recuperação de carta de condução, acompanhamento em estruturas de saúde,\n ações de sensibilização, acompanhamento interno ou necessidade pontual de verificação.\n Constituem testes rápidos de orientação, úteis para obter uma primeira indicação.\n \u003c\/p\u003e\n\n \u003cp\u003e\n No meio profissional, a utilização de testes de rastreio deve enquadrar-se num contexto claro,\n proporcional e conforme as regras aplicáveis, especialmente quando os postos em causa apresentam\n um risco particular para a segurança das pessoas. A AMA Prévention acompanha as empresas\n na escolha das referências mais adequadas às suas necessidades.\n \u003c\/p\u003e\n\n \u003ch3\u003eEncomende os seus testes urinários Drugdiag® cassete\u003c\/h3\u003e\n\n \u003cp\u003e\n Encomende os seus \u003cstrong\u003etestes urinários Drugdiag® cassete\u003c\/strong\u003e, \u003cstrong\u003etestes urinários THC\u003c\/strong\u003e,\n \u003cstrong\u003etestes urinários multi-drogas\u003c\/strong\u003e e dispositivos de rastreio profissional diretamente\n online na AMA Prévention. Expedição rápida em 24h com DPD, serviço de apoio ao cliente eficiente\n e acompanhamento profissional para escolher o teste mais adequado à sua situação.\n \u003c\/p\u003e\n\n \u003cp\u003e\n \u003cstrong\u003e\n Para encomendas em volume, necessidades profissionais ou campanhas de prevenção,\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\"\u003epeça um orçamento personalizado à AMA Prévention\u003c\/a\u003e.\n \u003c\/strong\u003e\n \u003c\/p\u003e\n\u003c\/section\u003e","products":[{"product_id":"test-urinaire-cassette-6-drogues","title":"Teste Urinário 6 drogas Drugdiag® 6","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6 urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário 6 drogas\u003c\/span\u003e\n \n \u003ch2 class=\"ama-bsafe-title\"\u003e\n Drugdiag® 6: teste urinário multi-drogas profissional\n \u003c\/h2\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n O \u003cstrong\u003eteste urinário Drugdiag® 6 drogas\u003c\/strong\u003e é um dispositivo de rastreio fiável, preciso e conforme às exigências médicas. Concebido pelo laboratório francês \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, nº1 em testes de diagnóstico rápido, permite a deteção simultânea de \u003cstrong\u003e6 famílias de substâncias psicoativas\u003c\/strong\u003e na urina.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Procura as seguintes famílias: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e canábis, \u003cstrong\u003eCOC\u003c\/strong\u003e cocaína, \u003cstrong\u003eAMP\u003c\/strong\u003e anfetaminas, \u003cstrong\u003eMET\u003c\/strong\u003e metanfetaminas, \u003cstrong\u003eMOP\u003c\/strong\u003e opiáceos e \u003cstrong\u003eBUP\u003c\/strong\u003e buprenorfina.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Recomendado para uso profissional, médico, institucional ou pessoal, integra-se numa abordagem estruturada de prevenção: empregadores, medicina do trabalho, estabelecimentos de saúde, acompanhamento adictológico, postos sensíveis e autoavaliação responsável.\n \u003c\/p\u003e\n \n \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDeteção simultânea de 6 famílias\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFormato urinário de leitura rápida\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUso em saúde, empresa e autoavaliação\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 famílias alvo\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstâncias detetadas\u003c\/h2\u003e\n\n \u003cp\u003e\n O teste urinário Drugdiag® 6 deteta as 6 famílias de substâncias psicoativas mais frequentemente encontradas na prática profissional, clínica e preventiva.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis:\u003c\/strong\u003e metabólito urinário do THC, associado ao consumo de canábis, resina, flores ou produtos contendo THC.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína:\u003c\/strong\u003e cocaína, crack e metabólitos relacionados detetáveis na urina.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e estimulantes do tipo anfetamínico, speed e substâncias relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e crystal meth, ice e derivados relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos:\u003c\/strong\u003e morfina, heroína, ópio e compostos relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorfina:\u003c\/strong\u003e molécula usada nomeadamente em alguns tratamentos de substituição aos opiáceos.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Os limiares devem ser interpretados segundo as instruções do fabricante, o contexto clínico ou profissional e os objetivos do rastreio. Um resultado positivo rápido é sempre um resultado preliminar.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizações\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEmpresa, saúde, acompanhamento\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePrincipais utilizações\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePrevenção em empresa\u003c\/h3\u003e\n \u003cp\u003e\n Em conformidade com o espírito do artigo \u003cstrong\u003eL.4121-1 do Código do Trabalho\u003c\/strong\u003e, este teste pode integrar uma abordagem de prevenção de riscos em postos de segurança e proteção: condução de máquinas, transporte, construção, indústria, segurança privada ou setores sensíveis.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eUso médico e adictológico\u003c\/h3\u003e\n \u003cp\u003e\n O teste urinário Drugdiag® 6 é relevante para profissionais de saúde: acompanhamento de desintoxicação, consulta de adictologia, controlo de consumos e acompanhamento de tratamentos de substituição de opiáceos graças ao painel \u003cstrong\u003eBUP\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eAuto-controle pessoal\u003c\/h3\u003e\n \u003cp\u003e\n Pode ser usado em auto-controle antes de um evento importante, uma consulta médica, uma retoma de posto sensível ou no âmbito de uma iniciativa pessoal de redução ou cessação do consumo.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eVantagens do teste Drugdiag® 6\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eDeteção simultânea:\u003c\/strong\u003e 6 famílias de substâncias pesquisadas numa única análise.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eCobertura alargada:\u003c\/strong\u003e canábis, cocaína, anfetaminas, metanfetaminas, opiáceos e buprenorfina.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eResultado rápido:\u003c\/strong\u003e leitura visual simples em poucos minutos conforme o manual.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante francês:\u003c\/strong\u003e dispositivo da gama Drugdiag® do laboratório Toda Pharma.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade profissional:\u003c\/strong\u003e certificação CE e ambiente de qualidade ISO 13485.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eAdequado ao Plano Joana:\u003c\/strong\u003e relevante para as ações de prevenção em empresa e a segurança dos postos sensíveis.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso polivalente:\u003c\/strong\u003e saúde, empresa, instituições e auto-controle pessoal.\u003c\/li\u003e\n \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDurações urinárias\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDurações de deteção urinária\u003c\/h2\u003e\n\n \u003cp\u003e\n A duração da deteção na urina depende de muitos fatores: frequência e quantidade de consumo, metabolismo, hidratação, função renal, antiguidade do uso e potência dos produtos consumidos.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis:\u003c\/strong\u003e duração indicativa variável de 1 a 30 dias conforme o perfil de consumo.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína:\u003c\/strong\u003e deteção urinária indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e deteção urinária indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e deteção urinária indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos:\u003c\/strong\u003e deteção urinária indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorfina :\u003c\/strong\u003e duração indicativa de deteção geralmente entre 1 e 7 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Estas durações são indicativas. Podem variar significativamente consoante o metabolismo, índice de massa corporal, função renal, frequência de uso, tratamentos em curso e concentração dos produtos consumidos.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eResultado negativo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado negativo indica que as substâncias pesquisadas não foram detetadas acima dos limiares de deteção do teste. Isso não garante a ausência absoluta de qualquer substância.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado positivo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado positivo indica uma reação compatível com a presença de uma ou mais famílias pesquisadas na urina. Para qualquer contexto oficial, profissional, médico ou contestado, pode ser necessária uma confirmação laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado inválido\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado inválido pode estar relacionado com uma má manipulação, volume insuficiente de amostra ou não cumprimento do tempo de leitura. Deve então repetir-se o teste com um novo dispositivo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualidade e fiabilidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e\n \u003cp\u003e\n O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal, permitindo uma leitura clara, rápida e adequada para usos profissionais.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eFiabilidade GC\/MS\u003c\/h3\u003e\n \u003cp\u003e\n A precisão deste dispositivo de rastreio urinário profissional foi comparada com o método de referência laboratorial, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e\n \u003cp\u003e\n Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e e um sistema de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003ePrincipais características\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eTipo de teste :\u003c\/strong\u003e teste urinário multi-droga com leitura rápida.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias pesquisadas :\u003c\/strong\u003e THC-COOH, COC, AMP, MET, MOP, BUP.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e dispositivo urinário profissional com leitura visual.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenção profissional, saúde, acompanhamento adictológico, autoavaliação.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante :\u003c\/strong\u003e laboratório francês Toda Pharma, n.º 1 em testes de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE e ISO 13485.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n O teste deve ser utilizado conforme o manual do fabricante. Em caso de resultado positivo, duvidoso ou contestado, recomenda-se a confirmação por análise laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eO que deteta o teste urinário Drugdiag® 6?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Deteta 6 famílias de substâncias na urina: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003ecocaína\u003c\/strong\u003e, \u003cstrong\u003eanfetaminas\u003c\/strong\u003e, \u003cstrong\u003emetanfetaminas\u003c\/strong\u003e, \u003cstrong\u003eopiáceos\u003c\/strong\u003e e \u003cstrong\u003ebuprenorfina\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003ePor que motivo a buprenorfina está incluída?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n A buprenorfina pode ser pesquisada em certos contextos médicos ou aditológicos, nomeadamente no acompanhamento de tratamentos de substituição aos opiáceos.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste é adequado para empresas?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sim, pode integrar-se numa abordagem de prevenção em postos sensíveis, respeitando o regulamento interno, a proporcionalidade, a confidencialidade e o quadro legal aplicável.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eQuanto tempo permanecem as drogas detetáveis na urina?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n A duração varia consoante a substância e o perfil. O THC-COOH pode permanecer detetável por mais tempo do que outras famílias, por vezes até 30 dias, dependendo dos perfis de consumo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eUm resultado positivo tem valor definitivo?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não. Um teste rápido fornece um resultado preliminar. Para qualquer decisão oficial, disciplinar, médica ou contestada, recomenda-se a confirmação por método analítico laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-cta\"\u003e\n \u003cp\u003ePrecisa de aconselhamento ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n Solicitar um orçamento\n \u003c\/a\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e destina-se a uso profissional ou pessoal, em conformidade com a legislação francesa e europeia em vigor. Fornece um resultado analítico preliminar. Em contexto judicial, disciplinar, médico ou contestado, qualquer resultado positivo deve ser confirmado por análise laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426433708356,"sku":"1046","price":11.9,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426433741124,"sku":"1046","price":59.5,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426433773892,"sku":"1046","price":113.05,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426433806660,"sku":"1046","price":252.88,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_produit_du_drugdiag_6.png?v=1777888318"},{"product_id":"test-urinaire-thc","title":"Teste Urinário THC (Cannabis) Drugdiag®","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag THC urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário cannabis\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® THC: teste urinário cannabis THC-COOH a 50 ng\/mL \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e O \u003cstrong\u003eteste urinário Drugdiag® THC\u003c\/strong\u003e é um dispositivo de despistagem profissional concebido para detetar o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principal metabolito urinário da cannabis. Ao contrário do teste salivar, que procura o THC ativo num período curto, o teste urinário permite identificar um consumo mais antigo. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Desenvolvido pela \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, laboratório francês nº1 em testes de diagnóstico rápido, este teste urinário de cannabis oferece um limite de deteção calibrado a \u003cstrong\u003e50 ng\/mL\u003c\/strong\u003e. É adequado para \u003cstrong\u003eauto-controle\u003c\/strong\u003e, \u003cstrong\u003erecuperação de carta\u003c\/strong\u003e, \u003cstrong\u003eacompanhamento médico\u003c\/strong\u003e e ações de prevenção em empresas. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Certificado \u003cstrong\u003eCE\u003c\/strong\u003e, conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e concebido para uso profissional, oferece uma leitura rápida, simples e fiável, com uma correlação superior a \u003cstrong\u003e99 %\u003c\/strong\u003e com o método de referência \u003cstrong\u003eGC\/MS\u003c\/strong\u003e. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDeteção do THC-COOH urinário\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eLimite padrão: 50 ng\/mL\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eIdeal para recuperação de carta, empresa e acompanhamento\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTHC-COOH urinário\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstância detetada\u003c\/h2\u003e \u003cp\u003e O teste urinário Drugdiag® THC procura o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principal metabolito da cannabis eliminado na urina. É adequado para situações em que o objetivo é verificar um consumo passado ou uma abstinência durante um período mais longo do que a saliva. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetabolito urinário da cannabis\u003c\/strong\u003e, resultante da degradação do THC pelo organismo.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eFlores\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis clássico\u003c\/strong\u003e, weed, marijuana, beuh.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eResina\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eHaxixe\u003c\/strong\u003e, pólen, resina de cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eConcentrados\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eÓleos, wax, rosin, e-líquidos\u003c\/strong\u003e ou produtos concentrados contendo cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eEdibles\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eProdutos alimentares infundidos\u003c\/strong\u003e, bolos, rebuçados ou preparações contendo cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eTHC-COOH\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCBD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eProdutos de CBD de espectro completo\u003c\/strong\u003e: um resultado positivo é possível em caso de acumulação de THC residual.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eRisco de positivo\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Este teste urinário não procura diretamente o Δ9-THC ativo na saliva. Procura o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, metabolito urinário da cannabis, o que permite uma janela de deteção mais longa. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eAtenção: CBD e resultado positivo\u003c\/h3\u003e \u003cp\u003e O \u003cstrong\u003eCBD puro\u003c\/strong\u003e não é o alvo do teste. No entanto, alguns produtos de CBD de espectro completo podem conter vestígios residuais de THC. \u003c\/p\u003e \u003cp\u003e Em caso de consumo regular de flores, resinas ou óleos CBD contendo THC residual, o THC pode acumular-se e ser eliminado na urina sob a forma de \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, com risco de resultado positivo. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUsos\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eCarta, trabalho, acompanhamento\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eUsos recomendados\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eRecuperação de carta\u003c\/h3\u003e \u003cp\u003e O teste urinário Drugdiag® THC é particularmente adequado para autoavaliação antes de uma consulta médica, comissão médica ou análise oficial. Ajuda a verificar se permanecem vestígios urinários de cannabis detetáveis. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eSegurança no trabalho\u003c\/h3\u003e \u003cp\u003e Nas empresas, pode integrar uma abordagem de prevenção de riscos em postos sensíveis ou de segurança, respeitando o regulamento interno, a confidencialidade e o enquadramento aplicável, nomeadamente o artigo \u003cstrong\u003eL.4121-1 do Código do Trabalho\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAcompanhamento médico e prevenção\u003c\/h3\u003e \u003cp\u003e Este teste pode ser usado no âmbito de acompanhamento médico, apoio à cessação do consumo de cannabis ou numa abordagem de prevenção individual, com resultado rápido e fácil de interpretar. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eVantagens do teste Drugdiag® THC\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eDeteção urinária de longa duração:\u003c\/strong\u003e pesquisa do THC-COOH, metabólito persistente da cannabis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLimite padrão:\u003c\/strong\u003e deteção calibrada a 50 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso versátil:\u003c\/strong\u003e recuperação de carta, autoavaliação, acompanhamento médico, empresa.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLeitura rápida:\u003c\/strong\u003e resultado visual em poucos minutos conforme o manual do fabricante.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFabricante francês:\u003c\/strong\u003e dispositivo da gama Drugdiag® do laboratório Toda Pharma.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualidade profissional:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE e norma ISO 13485.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUtilizado pelas Forças Armadas Francesas:\u003c\/strong\u003e selo UAF associado aos dispositivos da gama Toda Pharma.\u003c\/li\u003e \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eJanelas de deteção\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eJanelas de deteção urinária\u003c\/h2\u003e \u003cp\u003e Ao contrário do teste salivar, que indica um consumo recente, o teste urinário permite identificar um consumo passado através da deteção do \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eOcasional\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eUso único ou muito pontual:\u003c\/strong\u003e duração da deteção indicativa geralmente entre 1 e 3 dias.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eIndicativo\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eRegular\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eVárias utilizações por semana:\u003c\/strong\u003e deteção indicativa possível entre 5 e 12 dias consoante os perfis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eVariável\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCrónico\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eUso diário ou intensivo :\u003c\/strong\u003e deteção possível até 30 dias, por vezes mais em alguns indivíduos.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eVariável\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Os tempos de deteção são indicativos. Variam conforme o metabolismo, frequência de consumo, concentração dos produtos, IMC, hidratação e outros fatores individuais. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eResultado negativo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado negativo indica que o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e não foi detetado acima do limiar de 50 ng\/mL. Isto não garante a ausência absoluta de qualquer traço, mas indica que o limiar do teste não foi atingido. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eResultado positivo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado positivo indica uma reação compatível com a presença de \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e na urina. Para qualquer procedimento oficial ou contestado, recomenda-se confirmação por método analítico laboratorial. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eResultado inválido\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado inválido pode estar relacionado com uma manipulação incorreta, volume insuficiente de amostra ou não cumprimento do tempo de leitura. Deve então ser realizado um novo teste com um dispositivo novo. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eFiabilidade e qualidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e \u003cp\u003e O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal. Esta tecnologia permite uma leitura visual clara, rápida e adequada para usos profissionais. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eFiabilidade GC\/MS\u003c\/h3\u003e \u003cp\u003e A precisão do teste foi comparada com o método de referência laboratorial, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e), com uma correlação de exatidão superior a \u003cstrong\u003e99 %\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e \u003cp\u003e Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e e um sistema de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003ePrincipais características\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTipo de teste :\u003c\/strong\u003e teste urinário de cannabis de leitura rápida.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstância pesquisada :\u003c\/strong\u003e THC-COOH, metabolito urinário da cannabis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLimiar de deteção :\u003c\/strong\u003e 50 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e cassete urinária embalada individualmente.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eEmbalagem :\u003c\/strong\u003e embalagem individual selada com instruções de uso em francês na embalagem.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenção, autoavaliação, acompanhamento médico, recuperação de carta de condução e empresa.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e O teste deve ser utilizado conforme as instruções do fabricante. Em caso de resultado positivo, duvidoso ou contestado, a confirmação por análise laboratorial é a referência. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eO que exatamente deteta o teste urinário Drugdiag® THC?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Deteta o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principal metabólito urinário do cannabis. Este metabólito pode permanecer detetável por mais tempo do que o THC ativo detetado na saliva. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQual a diferença em relação a um teste salivar de THC?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e O teste salivar procura principalmente o THC ativo numa janela curta, geralmente relacionada com consumo recente. O teste urinário procura o THC-COOH, que pode permanecer presente por mais tempo no organismo. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eEste teste é adequado para a recuperação da carta de condução?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sim. É particularmente útil para o auto controlo antes de uma consulta médica ou análise oficial, pois permite verificar se o THC-COOH ainda é detetável na urina. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eO CBD pode tornar este teste positivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sim, em alguns casos. O CBD puro não é o alvo do teste, mas produtos de CBD que contenham vestígios residuais de THC podem causar um resultado positivo, especialmente em caso de consumo regular. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQuanto tempo o cannabis permanece detetável na urina?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A duração depende do perfil de consumo. Pode ser cerca de 1 a 3 dias para uso ocasional, 5 a 12 dias para uso regular, e até 30 dias ou mais em alguns consumidores crónicos. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eUm resultado positivo tem valor legal definitivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Não. Um resultado positivo num teste rápido é um resultado preliminar. Para qualquer procedimento oficial, é necessária uma confirmação por método analítico laboratorial. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003ePrecisa de aconselhamento ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Pedir um orçamento \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este teste é um dispositivo de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e destinado a detectar de forma indicativa a presença de \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e na urina. Um resultado positivo preliminar indica a possível presença de metabólitos de cannabis, mas não constitui uma prova legal definitiva. Recomenda-se uma confirmação por método analítico laboratorial para qualquer procedimento oficial. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426433872196,"sku":"1041-THC","price":5.99,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426433904964,"sku":"1041-THC","price":29.95,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426433937732,"sku":"1041-THC","price":56.91,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426433970500,"sku":"1041-THC","price":127.29,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Image_produit_Drgdiag_THC.png?v=1777887804"},{"product_id":"test-urinaire-cassette-11-drogues","title":"Teste Urinário 11 Drogas Drugdiag® 11","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 11 urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário 11 drogas\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® 11: teste urinário multi-drogas de largo espectro \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e O \u003cstrong\u003eteste urinário Drugdiag® 11 drogas\u003c\/strong\u003e, desenvolvido pelo laboratório francês \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, nº1 em testes de diagnóstico rápido, permite a \u003cstrong\u003edetecção simultânea de 11 famílias de drogas\u003c\/strong\u003e na urina. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Procura nomeadamente o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, as \u003cstrong\u003eanfetaminas\u003c\/strong\u003e, os \u003cstrong\u003ebarbitúricos\u003c\/strong\u003e, as \u003cstrong\u003ebenzodiazepinas\u003c\/strong\u003e, a \u003cstrong\u003ebuprenorfina\u003c\/strong\u003e, a \u003cstrong\u003ecocaína\u003c\/strong\u003e, a \u003cstrong\u003eMDMA\u003c\/strong\u003e, as \u003cstrong\u003emetanfetaminas\u003c\/strong\u003e, os \u003cstrong\u003eopiáceos\u003c\/strong\u003e, a \u003cstrong\u003emetadona\u003c\/strong\u003e e os \u003cstrong\u003eantidepressivos tricíclicos\u003c\/strong\u003e. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Este teste multi-drogas é particularmente adequado para \u003cstrong\u003eempresas\u003c\/strong\u003e, \u003cstrong\u003emédicos do trabalho\u003c\/strong\u003e, \u003cstrong\u003eestruturas de aditologia\u003c\/strong\u003e, \u003cstrong\u003eprofissionais de saúde\u003c\/strong\u003e e organizações que precisam de garantir ambientes com alto nível de responsabilidade. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDeteção simultânea de 11 famílias\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFormato urinário de leitura rápida\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUso empresarial, saúde e aditologia\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e11 famílias alvo\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstâncias detetadas\u003c\/h2\u003e \u003cp\u003e O teste urinário Drugdiag® 11 permite uma pesquisa alargada das principais famílias de substâncias psicoativas, incluindo tanto as drogas mais comuns, alguns medicamentos psicoativos e moléculas usadas no acompanhamento da dependência. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis:\u003c\/strong\u003e metabólito principal do THC, associado ao consumo de canábis, resina, flores ou produtos contendo THC.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e estimulantes do tipo anfetamínico, speed e substâncias relacionadas.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbitúricos:\u003c\/strong\u003e família de depressores do sistema nervoso central.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas:\u003c\/strong\u003e ansiolíticos, hipnóticos ou sedativos que podem alterar a vigilância.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorfina:\u003c\/strong\u003e molécula usada nomeadamente em alguns tratamentos de substituição aos opiáceos.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e10 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína:\u003c\/strong\u003e cocaína, crack e metabólitos relacionados detetáveis na urina.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA e substâncias relacionadas.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e crystal meth, ice e derivados relacionados.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos:\u003c\/strong\u003e morfina, heroína, ópio e compostos relacionados.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetadona:\u003c\/strong\u003e molécula usada nomeadamente em alguns tratamentos de substituição aos opiáceos.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAntidepressivos tricíclicos:\u003c\/strong\u003e família de medicamentos psicoativos pesquisada em certos contextos clínicos.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Os limiares devem ser interpretados de acordo com as instruções do fabricante, o contexto clínico ou profissional e os objetivos do rastreio. Em caso de resultado positivo, pode ser necessária uma confirmação laboratorial conforme o contexto. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizações\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEmpresa, saúde, segurança\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePrincipais utilizações\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003ePostos sensíveis e setores de risco\u003c\/h3\u003e \u003cp\u003e O Drugdiag® 11 é particularmente adequado para postos de segurança e proteção: transporte, logística, construção civil, indústria pesada, manutenção de instalações sensíveis, energia, locais classificados ou ambientes de alta responsabilidade. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAcompanhamento terapêutico e adictologia\u003c\/h3\u003e \u003cp\u003e Graças à deteção de \u003cstrong\u003emetadona\u003c\/strong\u003e, \u003cstrong\u003ebuprenorfina\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e, este teste pode ser útil para CSAPA, médicos, psiquiatras, clínicas e estruturas de desintoxicação para documentar um acompanhamento, em complemento da consulta clínica. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003ePrevenção na empresa\u003c\/h3\u003e \u003cp\u003e Quando previsto no regulamento interno, este teste pode ser integrado numa procedimento interno de prevenção: controlo direcionado, situação de risco, acidente, incidente ou abordagem global de segurança. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAuto-controle responsável\u003c\/h3\u003e \u003cp\u003e O Drugdiag® 11 pode também ser usado por particulares numa abordagem de auto-controle antes de uma consulta médica, uma visita profissional ou um procedimento administrativo. A confirmação laboratorial continua a ser necessária em qualquer contexto oficial. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003eVantagens do teste Drugdiag® 11\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eDeteção alargada :\u003c\/strong\u003e 11 famílias de substâncias pesquisadas numa única análise.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFerramenta versátil :\u003c\/strong\u003e empresas, medicina do trabalho, adictologia, estruturas médico-sociais, instituições e auto-controle.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLeitura rápida :\u003c\/strong\u003e resultado visual em poucos minutos conforme o manual do fabricante.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFabricante francês :\u003c\/strong\u003e dispositivo da gama Drugdiag® do laboratório Toda Pharma.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualidade profissional :\u003c\/strong\u003e marcação CE, ambiente de qualidade ISO 13485 e rastreabilidade dos lotes.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eAcompanhamento adictológico :\u003c\/strong\u003e painéis BUP, MTD e TCA úteis em certos contextos médicos.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003ePolítica de prevenção :\u003c\/strong\u003e integrável numa abordagem global de informação, formação e acompanhamento.\u003c\/li\u003e \u003c\/ul\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eUtilização regulamentada na empresa\u003c\/h3\u003e \u003cp\u003e No ambiente profissional, a utilização de testes de despistagem deve estar prevista no regulamento interno, justificada pela natureza das tarefas e implementada em conformidade com o Código do Trabalho, os direitos dos trabalhadores e a confidencialidade. \u003c\/p\u003e \u003cp\u003e O teste Drugdiag® 11 integra-se numa política global de prevenção e nunca substitui a avaliação clínica nem as análises de confirmação em laboratório quando estas são necessárias. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTempos urinários\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTempos de deteção urinária\u003c\/h2\u003e \u003cp\u003e O tempo de deteção das substâncias na urina depende de muitos fatores: frequência de consumo, quantidade, metabolismo, estado de saúde, função renal, hidratação, tratamento em curso e antiguidade do uso. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis :\u003c\/strong\u003e duração indicativa muito variável conforme a frequência e intensidade do consumo.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbitúricos :\u003c\/strong\u003e duração indicativa variável conforme a molécula, dose e uso.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 5 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas :\u003c\/strong\u003e duração indicativa variável, podendo ser mais longa em caso de tratamento prolongado.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias+\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eBUP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBuprenorfina :\u003c\/strong\u003e duração indicativa variável conforme a dose, frequência e duração do tratamento.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 3 dias.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 3 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetadona :\u003c\/strong\u003e duração indicativa variável conforme o esquema terapêutico.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAntidepressivos tricíclicos :\u003c\/strong\u003e duração indicativa variável conforme a molécula e a posologia.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Estas durações têm um valor indicativo e nunca podem constituir uma prova absoluta de consumo ou abstinência. Devem ser interpretadas segundo o contexto clínico, as declarações da pessoa e, se necessário, exames complementares. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eResultado negativo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado negativo indica que as famílias pesquisadas não foram detetadas acima dos limiares do teste. Isso não garante a ausência absoluta de qualquer substância. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eResultado positivo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado positivo indica uma reação compatível com a presença de uma ou várias famílias pesquisadas na urina. Recomenda-se confirmação laboratorial em qualquer contexto oficial, médico, disciplinar ou contestado. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eResultado inválido\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado inválido pode estar relacionado com uma má manipulação, volume insuficiente de amostra ou não cumprimento do tempo de leitura. Deve então ser realizado um novo teste com um dispositivo novo. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualidade e fiabilidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e \u003cp\u003e O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal, permitindo uma leitura clara, rápida e adequada para usos profissionais. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eFiabilidade GC\/MS\u003c\/h3\u003e \u003cp\u003e A precisão deste dispositivo profissional de rastreio urinário foi comparada ao método de referência laboratorial, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e). \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e \u003cp\u003e Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e, um ambiente de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e uma rastreabilidade completa dos lotes. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003ePrincipais características\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTipo de teste :\u003c\/strong\u003e teste urinário multi-drogas de leitura rápida.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstâncias pesquisadas :\u003c\/strong\u003e THC-COOH, AMP, BAR, BZO, BUP, COC, MDMA, MET, MOP, MTD, TCA.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormato:\u003c\/strong\u003e teste urinário simples de usar com leitura visual das tiras de resultado.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso:\u003c\/strong\u003e prevenção profissional, medicina do trabalho, dependência, acompanhamento terapêutico, auto-controle.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFabricante:\u003c\/strong\u003e laboratório francês Toda Pharma, nº1 em teste de diagnóstico rápido.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualidade:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE e ISO 13485.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e O teste deve ser utilizado conforme o manual do fabricante. Em caso de resultado positivo, duvidoso ou contestado, recomenda-se a confirmação por análise laboratorial. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eO que deteta o teste urinário Drugdiag® 11?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Deteta 11 famílias de substâncias na urina: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eBAR\u003c\/strong\u003e, \u003cstrong\u003eBZO\u003c\/strong\u003e, \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMOP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eA quem se destina este teste?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Destina-se a empresas, médicos do trabalho, estruturas de dependência, profissionais de saúde, organizações expostas a riscos de segurança e particulares que desejem realizar um auto-controle responsável. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eEste teste é adequado para acompanhamento de dependência?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sim. Os painéis \u003cstrong\u003eBUP\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e, associados às outras famílias pesquisadas, podem ser úteis em alguns acompanhamentos terapêuticos ou de dependência, em complemento à avaliação clínica. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003ePode ser utilizado na empresa?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sim, se a sua utilização estiver prevista no regulamento interno, justificada pela natureza das tarefas, proporcional ao risco e implementada em conformidade com o Código do Trabalho, os direitos dos trabalhadores e a confidencialidade. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eUm resultado positivo tem valor definitivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Não. Um teste rápido fornece um resultado analítico preliminar. Em qualquer contexto oficial, judicial, administrativo, disciplinar, médico ou contestado, recomenda-se a confirmação por método analítico de laboratório. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003ePrecisa de aconselhamento ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Pedir um orçamento \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e destina-se a uso profissional e, quando aplicável, a um uso pessoal responsável, em conformidade com a legislação francesa e europeia em vigor. Fornece um resultado analítico preliminar e não substitui uma análise de confirmação em laboratório no âmbito de um processo judicial, administrativo, médico, disciplinar ou contestado. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426434199876,"sku":"10411","price":14.94,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426434232644,"sku":"10411","price":74.7,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426434265412,"sku":"10411","price":141.93,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426434298180,"sku":"10411","price":317.47,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_Poduit_du_drugdiag_11.png?v=1777888364"}],"url":"https:\/\/ama-prevention.com\/pt-pt\/collections\/toda-drugdiag-cassete.oembed","provider":"AMA Prévention ","version":"1.0","type":"link"}